Lista de obras -

Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care

artículo científico publicado en 2014

An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder

artículo científico publicado en 2008

Characteristics of insured and noninsured outpatients with depression in STAR(*)D.

artículo científico publicado en 2005

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

artículo científico publicado en 2011

Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D.

artículo científico publicado en 2008

Do atypical features affect outcome in depressed outpatients treated with citalopram?

artículo científico publicado en 2009

Effect of age at onset on the course of major depressive disorder.

artículo científico publicado en 2007

Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study

artículo científico publicado en 2011

Effects of Race and Ethnicity on Depression Treatment Outcomes: The CO-MED Trial

Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial

artículo científico publicado en 2011

Ethnicity/race and outcome in the treatment of depression: results from STAR*D.

artículo científico publicado en 2007

Identifying risk for attrition during treatment for depression

artículo científico publicado en 2009

Income and attrition in the treatment of depression: a STAR*D report.

artículo científico publicado en 2009

Increase in work productivity of depressed individuals with improvement in depressive symptom severity

artículo científico publicado en 2013

Insured and Non-insured Depressed Outpatients: How Do They Compare?

artículo científico publicado en 2007

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

artículo científico publicado en 2011

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

artículo científico publicado en 2008

Lista de obras de

Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care

An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder

Characteristics of insured and noninsured outpatients with depression in STAR(*)D.

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D.

Do atypical features affect outcome in depressed outpatients treated with citalopram?

Effect of age at onset on the course of major depressive disorder.

Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study

Effects of Race and Ethnicity on Depression Treatment Outcomes: The CO-MED Trial

Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial

Ethnicity/race and outcome in the treatment of depression: results from STAR*D.

Identifying risk for attrition during treatment for depression

Income and attrition in the treatment of depression: a STAR*D report.

Increase in work productivity of depressed individuals with improvement in depressive symptom severity

Insured and Non-insured Depressed Outpatients: How Do They Compare?

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.